A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on Methotrexate
Clinical trial NCT03257852 · COMPLETED
Trial details
- NCT number
- NCT03257852
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-29
- Primary completion
- 2018-09-19
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.